HT-29 as a Preclinical Model for Colorectal Cancer

For men and women combined, colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States. The American Cancer Society estimates that over 49,000 individuals will die of CRC in 2016. Fortunately, the death rate from CRC has been declining in both men and women over the past several decades. Early … Continue reading HT-29 as a Preclinical Model for Colorectal Cancer